Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1

Brain, Behavior, and Immunity

Volumn 59, Issue , 2017, Pages 322-332

  Lian, Yong Jie ^a   Gong, Hong ^a   Wu, Teng Yun ^b   Su, Wen Jun ^a   Zhang, Yi ^a   Yang, Yuan Yuan ^a   Peng, Wei ^a   Zhang, Ting ^a   Zhou, Jiang Rui ^a   Jiang, Chun Lei ^a   Wang, Yun Xia ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

Depression; HMGB1 protein; Myelin basic protein; Redox forms; TNF

Indexed keywords

GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; MYELIN BASIC PROTEIN; PLERIXAFOR; RECOMBINANT PROTEIN; RESATORVID; TUMOR NECROSIS FACTOR; HMGB1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN TISSUE; CONTROLLED STUDY; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMOBILITY; IN VIVO STUDY; MALE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OPEN FIELD TEST; OXIDATION; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STRESS; SUCROSE PREFERENCE TEST; TAIL SUSPENSION TEST; UPREGULATION; WESTERN BLOTTING; ANHEDONIA; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECT; GENETICS; HIPPOCAMPUS; HUMAN; IMMOBILIZATION; INFLAMMATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MENTAL STRESS; METABOLISM; MOTOR ACTIVITY; OXIDATION REDUCTION REACTION; PSYCHOLOGY;

ANHEDONIA; ANIMALS; DEPRESSION; HINDLIMB SUSPENSION; HIPPOCAMPUS; HMGB1 PROTEIN; HUMANS; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; OXIDATION-REDUCTION; RECOMBINANT PROTEINS; STRESS, PSYCHOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84994706949     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.09.017     Document Type: Article

References (79)

1. Agalave, N.M., Svensson, C.I., Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain. Mol. Med. 20 (2014), 569–578.
2. Alfonso-Loeches, S., Pascual, M., Gomez-Pinedo, U., Pascual-Lucas, M., Renau-Piqueras, J., Guerri, C., Toll-like receptor 4 participates in the myelin disruptions associated with chronic alcohol abuse. Glia 60 (2012), 948–964.
3. Andersson, U., Tracey, K.J., HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 29 (2011), 139–162.
4. Bae, J.-S., Role of high mobility group box 1 in inflammatory disease: focus on sepsis. Arch. Pharmacal Res. 35 (2012), 1511–1523.
5. Balosso, S., Liu, J., Bianchi, M.E., Vezzani, A., Disulfide-containing high mobility group box-1 promotes N-methyl-D-aspartate receptor function and excitotoxicity by activating Toll-like receptor 4-dependent signaling in hippocampal neurons. Antioxid. Redox Signal. 21 (2014), 1726–1740.
6. Bianchi, M.E., Manfredi, A.A., High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol. Rev. 220 (2007), 35–46.
7. Bianchi, R., Giambanco, I., Donato, R., S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha. Neurobiol. Aging 31 (2010), 665–677.
8. Calderon, T.M., Eugenin, E.A., Lopez, L., Kumar, S.S., Hesselgesser, J., Raine, C.S., Berman, J.W., A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J. Neuroimmunol. 177 (2006), 27–39.
9. Carty, M., Bowie, A.G., Evaluating the role of Toll-like receptors in diseases of the central nervous system. Biochem. Pharmacol. 81 (2011), 825–837.
10. Chen, Y., Huang, X.J., Yu, N., Xie, Y., Zhang, K., Wen, F., Liu, H., Di, Q., HMGB1 contributes to the expression of P-glycoprotein in mouse epileptic brain through toll-like receptor 4 and receptor for advanced glycation end products. PLoS ONE, 10, 2015, e0140918.
11. Chen, S.D., Wang, Y.L., Liang, S.F., Shaw, F.Z., Rapid amygdala kindling causes motor seizure and comorbidity of anxiety- and depression-like behaviors in rats. Front. Behav. Neurosci., 10, 2016, 129.
12. Cheng, Y., Pardo, M., Armini Rde, S., Martinez, A., Mouhsine, H., Zagury, J.F., Jope, R.S., Beurel, E., Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior. Brain Behav. Immun. 53 (2016), 207–222.
13. Cinatl, J., Morgenstern, B., Bauer, G., Chandra, P., Rabenau, H., Doerr, H.W., Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet (London, England) 361 (2003), 2045–2046.
14. Clark, I.A., Vissel, B., Amyloid beta: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease. Br. J. Pharmacol. 172 (2015), 3714–3727.
15. Cryan, J.F., Mombereau, C., Vassout, A., The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci. Biobehav. Rev. 29 (2005), 571–625.
16. Dantzer, R., Depression and inflammation: an intricate relationship. Biol. Psychiatry 71 (2012), 4–5.
17. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9 (2008), 46–56.
18. Deane, R., Singh, I., Sagare, A.P., Bell, R.D., Ross, N.T., LaRue, B., Love, R., Perry, S., Paquette, N., Deane, R.J., Thiyagarajan, M., Zarcone, T., Fritz, G., Friedman, A.E., Miller, B.L., Zlokovic, B.V., A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease. J. Clin. Investig. 122 (2012), 1377–1392.
19. Ferrari, S., Ronfani, L., Calogero, S., Bianchi, M.E., The mouse gene coding for high mobility group 1 protein (HMG1). J. Biol. Chem. 269 (1994), 28803–28808.
20. Fontella, F.U., Siqueira, I.R., Vasconcellos, A.P., Tabajara, A.S., Netto, C.A., Dalmaz, C., Repeated restraint stress induces oxidative damage in rat hippocampus. Neurochem. Res. 30 (2005), 105–111.
21. Frank, M.G., Weber, M.D., Watkins, L.R., Maier, S.F., Stress sounds the alarmin: the role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming. Brain Behav. Immun., 2015.
22. Frank, M.G., Weber, M.D., Fonken, L.K., Hershman, S.A., Watkins, L.R., Maier, S.F., The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: a role for the NLRP3 inflammasome. Brain Behav. Immun. 55 (2016), 215–224.
23. Gambarana, C., Scheggi, S., Tagliamonte, A., Tolu, P., De Montis, M.G., Animal models for the study of antidepressant activity. Brain Res. Brain Res. Protoc. 7 (2001), 11–20.
24. Garate, I., Garcia-Bueno, B., Madrigal, J.L., Bravo, L., Berrocoso, E., Caso, J.R., Mico, J.A., Leza, J.C., Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression. J. Neuroinflamm., 8, 2011, 151.
25. Gariboldi, M., De Gregorio, L., Ferrari, S., Manenti, G., Pierotti, M.A., Bianchi, M.E., Dragani, T.A., Mapping of the Hmg1 gene and of seven related sequences in the mouse. Mamm. Genome 6 (1995), 581–585.
26. Goldstein, R.S., Gallowitsch-Puerta, M., Yang, L., Rosas-Ballina, M., Huston, J.M., Czura, C.J., Lee, D.C., Ward, M.F., Bruchfeld, A.N., Wang, H., Lesser, M.L., Church, A.L., Litroff, A.H., Sama, A.E., Tracey, K.J., Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock (Augusta, Ga.) 25 (2006), 571–574.
27. Goodwin, G.H., Sanders, C., Johns, E.W., A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur. J. Biochem./FEBS 38 (1973), 14–19.
28. Harris, H.E., Andersson, U., Pisetsky, D.S., HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat. Rev. Rheumatol. 8 (2012), 195–202.
29. Hreggvidsdottir, H.S., Ostberg, T., Wahamaa, H., Schierbeck, H., Aveberger, A.C., Klevenvall, L., Palmblad, K., Ottosson, L., Andersson, U., Harris, H.E., The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J. Leukoc. Biol. 86 (2009), 655–662.
30. Hua, F., Tang, H., Wang, J., Prunty, M.C., Hua, X., Sayeed, I., Stein, D.G., TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice. J. Cereb. Blood Flow Metab., 2015, 536–542.
31. Huang, Y., Henry, C.J., Dantzer, R., Johnson, R.W., Godbout, J.P., Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol. Aging 29 (2008), 1744–1753.
32. Kang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., Sun, X., Wang, H., Wang, Q., Tsung, A., Billiar, T.R., Zeh Iii, H.J., Lotze, M.T., Tang, D., HMGB1 in health and disease. Mol. Aspects Med. 40 (2014), 1–116.
33. Kokkola, R., Li, J., Sundberg, E., Aveberger, A.C., Palmblad, K., Yang, H., Tracey, K.J., Andersson, U., Harris, H.E., Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum. 48 (2003), 2052–2058.
34. Konsman, J.-P., 2003. The mouse brain in stereotaxic coordinates: Second Edition (Deluxe) By Paxinos G. and Franklin, K.B.J., Academic Press, New York, 2001, 827–828, ISBN 0-12-547637-X. Psychoneuroendocrino, 28.
35. Li, D., Lei, C., Zhang, S., Zhang, S., Liu, M., Wu, B., Blockade of high mobility group box-1 signaling via the receptor for advanced glycation end-products ameliorates inflammatory damage after acute intracerebral hemorrhage. Neurosci. Lett. 609 (2015), 109–119.
36. Li, L., Tu, J., Jiang, Y., Zhou, J., Yabe, S., Schust, D.J., Effects of lipopolysaccharide on human first trimester villous cytotrophoblast cell function in vitro. Biol. Reprod., 94, 2016, 33.
37. Liesz, A., Dalpke, A., Mracsko, E., Antoine, D.J., Roth, S., Zhou, W., Yang, H., Na, S.-Y., Akhisaroglu, M., Fleming, T., Eigenbrod, T., Nawroth, P.P., Tracey, K.J., Veltkamp, R., DAMP signaling is a key pathway inducing immune modulation after brain injury. J. Neurosci. 35 (2015), 583–598.
38. Liu, Y.N., Peng, Y.L., Liu, L., Wu, T.Y., Zhang, Y., Lian, Y.J., Yang, Y.Y., Kelley, K.W., Jiang, C.L., Wang, Y.X., TNFalpha mediates stress-induced depression by upregulating indoleamine 2,3-dioxygenase in a mouse model of unpredictable chronic mild stress. Eur. Cytokine Netw. 26 (2015), 15–25.
39. Lucca, G., Comim, C.M., Valvassori, S.S., Reus, G.Z., Vuolo, F., Petronilho, F., Dal-Pizzol, F., Gavioli, E.C., Quevedo, J., Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochem. Int. 54 (2009), 358–362.
40. Macaione, V., Aguennouz, M., Rodolico, C., Mazzeo, A., Patti, A., Cannistraci, E., Colantone, L., Di Giorgio, R.M., De Luca, G., Vita, G., RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy. Acta Neurol. Scand. 115 (2007), 115–121.
41. MacDowell, K.S., Caso, J.R., Martin-Hernandez, D., Madrigal, J.I., Leza, J.C., Garcia-Bueno, B., Paliperidone prevents brain toll-like receptor 4 pathway activation and neuroinflammation in rat models of acute and chronic restraint stress. Int. J. Neuropsychopharmacol., 18, 2015.
42. Matsunaga, N., Tsuchimori, N., Matsumoto, T., Ii, M., TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. Mol. Pharmacol. 79 (2011), 34–41.
43. Mazarati, A., Maroso, M., Iori, V., Vezzani, A., Carli, M., High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products. Exp. Neurol. 232 (2011), 143–148.
44. McDonald, E.M., Mann, A.H., Thomas, H.C., Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers. Lancet (London, England) 2 (1987), 1175–1178.
45. Miller, A.H., Raison, C.L., The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol. 16 (2016), 22–34.
46. Mollica, L., De Marchis, F., Spitaleri, A., Dallacosta, C., Pennacchini, D., Zamai, M., Agresti, A., Trisciuoglio, L., Musco, G., Bianchi, M.E., Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem. Biol. 14 (2007), 431–441.
47. Monje, M.L., Toda, H., Palmer, T.D., Inflammatory blockade restores adult hippocampal neurogenesis. Science 302 (2003), 1760–1765.
48. Mosebach, J., Keilhoff, G., Gos, T., Schiltz, K., Schoeneck, L., Dobrowolny, H., Mawrin, C., Muller, S., Schroeter, M.L., Bernstein, H.G., Bogerts, B., Steiner, J., Increased nuclear Olig1-expression in the pregenual anterior cingulate white matter of patients with major depression: a regenerative attempt to compensate oligodendrocyte loss?. J. Psychiatr. Res. 47 (2013), 1069–1079.
49. Musumeci, D., Roviello, G.N., Montesarchio, D., An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol. Ther. 141 (2014), 347–357.
50. Nogueira-Machado, J.A., de Oliveira Volpe, C.M., HMGB-1 as a target for inflammation controlling. Recent Pat. Endocr., Metab. Immune Drug Discovery 6 (2012), 201–209.
51. O'Connor, K.A., Hansen, M.K., Rachal Pugh, C., Deak, M.M., Biedenkapp, J.C., Milligan, E.D., Johnson, J.D., Wang, H., Maier, S.F., Tracey, K.J., Watkins, L.R., Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects. Cytokine 24 (2003), 254–265.
52. Pandey, G.N., Rizavi, H.S., Ren, X., Bhaumik, R., Dwivedi, Y., Toll-like receptors in the depressed and suicide brain. J. Psychiatr. Res. 53 (2014), 62–68.
53. Peng, Y.-L., Liu, Y.-N., Liu, L., Wang, X., Jiang, C.-L., Wang, Y.-X., Inducible nitric oxide synthase is involved in the modulation of depressive behaviors induced by unpredictable chronic mild stress. J. Neuroinflamm., 9, 2012 75-75.
54. Raison, C.L., Capuron, L., Miller, A.H., Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27 (2006), 24–31.
55. Saeedi, M., Morteza-Semnani, K., Ghoreishi, M.R., The treatment of atopic dermatitis with licorice gel. J. Dermatol. Treat. 14 (2003), 153–157.
56. Schiepers, O.J.G., Wichers, M.C., Maes, M., Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005), 201–217.
57. Schiraldi, M., Raucci, A., Munoz, L.M., Livoti, E., Celona, B., Venereau, E., Apuzzo, T., De Marchis, F., Pedotti, M., Bachi, A., Thelen, M., Varani, L., Mellado, M., Proudfoot, A., Bianchi, M.E., Uguccioni, M., HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J. Exp. Med. 209 (2012), 551–563.
58. Takata, K., Takada, T., Ito, A., Asai, M., Tawa, M., Saito, Y., Ashihara, E., Tomimoto, H., Kitamura, Y., Shimohama, S., Microglial amyloid-beta1-40 phagocytosis dysfunction is caused by high-mobility group box protein-1: implications for the pathological progression of Alzheimer's disease. Int. J. Alzheimer's Dis., 2012, 2012, 685739.
59. Tang, D., Kang, R., Zeh, H.J., Lotze, M.T., High-mobility group box 1, oxidative stress, and disease. Antioxid. Redox Signal. 14 (2011), 1315–1335.
60. Tang, Y., Zhao, X., Antoine, D., Xiao, X., Wang, H., Andersson, U., Billiar, T.R., Tracey, K.J., Lu, B., Regulation of posttranslational modifications of HMGB1 during immune responses. Antioxid. Redox Signal., 2016.
61. van Rossum, T.G., Vulto, A.G., Hop, W.C., Brouwer, J.T., Niesters, H.G., Schalm, S.W., Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trial. J. Gastroenterol. Hepatol. 14 (1999), 1093–1099.
62. Venereau, E., Casalgrandi, M., Schiraldi, M., Antoine, D.J., Cattaneo, A., De Marchis, F., Liu, J., Antonelli, A., Preti, A., Raeli, L., Shams, S.S., Yang, H., Varani, L., Andersson, U., Tracey, K.J., Bachi, A., Uguccioni, M., Bianchi, M.E., Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J. Exp. Med. 209 (2012), 1519–1528.
63. Volz, H.C., Laohachewin, D., Seidel, C., Lasitschka, F., Keilbach, K., Wienbrandt, A.R., Andrassy, J., Bierhaus, A., Kaya, Z., Katus, H.A., Andrassy, M., S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-kappa B signaling. Basic Res. Cardiol., 107, 2012, 250.
64. Wang, C., Liu, X.X., Huang, K.B., Yin, S.B., Wei, J.J., Hu, Y.F., Gu, Y., Zheng, G.Q., Preconditioning with recombinant high-mobility group box 1 induces ischemic tolerance in a rat model of focal cerebral ischemia-reperfusion. J. Neurochem. 137 (2016), 576–588.
65. Wang, H., Han, X., Wittchen, E.S., Hartnett, M.E., TNF-alpha mediates choroidal neovascularization by upregulating VEGF expression in RPE through ROS-dependent beta-catenin activation. Mol. Vis. 22 (2016), 116–128.
66. − absorption in medullary thick ascending limb through RAGE-Rho-ROCK-mediated inhibition of basolateral Na+/H+ exchange. Am. J. Physiol. Renal Physiol., 2016 ajprenal 00185 02016.
67. Weber, M.D., Frank, M.G., Tracey, K.J., Watkins, L.R., Maier, S.F., Stress induces the danger-associated molecular pattern HMGB-1 in the hippocampus of male Sprague Dawley rats: a priming stimulus of microglia and the NLRP3 inflammasome. J. Neurosci. 35 (2015), 316–324.
68. Wen, L., Huang, J.K., Johnson, B.H., Reeck, G.R., A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-1. Nucleic Acids Res. 17 (1989), 1197–1214.
69. Wen, J., Chen, C.H., Stock, A., Doerner, J., Gulinello, M., Putterman, C., Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice. Brain Behav. Immun. 54 (2016), 27–37.
70. Wu, T.-Y., Liu, L., Zhang, W., Zhang, Y., Liu, Y.-Z., Shen, X.-L., Gong, H., Yang, Y.-Y., Bi, X.-Y., Jiang, C.-L., Wang, Y.-X., High-mobility group box-1 was released actively and involved in LPS induced depressive-like behavior. J. Psychiatr. Res. 64 (2015), 99–106.
71. Yan, H.-C., Cao, X., Das, M., Zhu, X.-H., Gao, T.-M., Behavioral animal models of depression. Neurosci. Bull. 26 (2010), 327–337.
72. Yan, S., Zhang, X., Zheng, H., Hu, D., Zhang, Y., Guan, Q., Liu, L., Ding, Q., Li, Y., Clematichinenoside inhibits VCAM-1 and ICAM-1 expression in TNF-alpha-treated endothelial cells via NADPH oxidase-dependent IkappaB kinase/NF-kappaB pathway. Free Radical Biol. Med. 78 (2015), 190–201.
73. Yang, H., Lundbäck, P., Ottosson, L., Erlandsson-Harris, H., Venereau, E., Bianchi, M.E., Al-Abed, Y., Andersson, U., Tracey, K.J., Antoine, D.J., Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol. Med. 18 (2012), 250–259.
74. Yang, P., Gao, Z., Zhang, H., Fang, Z., Wu, C., Xu, H., Huang, Q.-J., Changes in proinflammatory cytokines and white matter in chronically stressed rats. Neuropsychiatr. Dis. Treat., 2015, 597–607.
75. Ying, C.J., Zhang, F., Zhou, X.Y., Hu, X.T., Chen, J., Wen, X.R., Sun, Y., Zheng, K.Y., Tang, R.X., Song, Y.J., Anti-inflammatory effect of astaxanthin on the sickness behavior induced by diabetes mellitus. Cell. Mol. Neurobiol. 35 (2015), 1027–1037.
76. Yu, Z., Ohtaki, Y., Kai, K., Sasano, T., Shimauchi, H., Yokochi, T., Takada, H., Sugawara, S., Kumagai, K., Endo, Y., Critical roles of platelets in lipopolysaccharide-induced lethality: effects of glycyrrhizin and possible strategy for acute respiratory distress syndrome. Int. Immunopharmacol. 5 (2005), 571–580.
77. Zhang, C., Mo, M., Ding, W., Liu, W., Yan, D., Deng, J., Luo, X., Liu, J., High-mobility group box 1 (HMGB1) impaired cardiac excitation-contraction coupling by enhancing the sarcoplasmic reticulum (SR) Ca(2+) leak through TLR4-ROS signaling in cardiomyocytes. J. Mol. Cell. Cardiol. 74 (2014), 260–273.
78. Zhang, Y., Liu, L., Liu, Y.Z., Shen, X.L., Wu, T.Y., Zhang, T., Wang, W., Wang, Y.X., Jiang, C.L., NLRP3 Inflammasome Mediates Chronic Mild Stress-Induced Depression in Mice via Neuroinflammation. Int. J. Neuropsychopharmacol., 2015.
79. Zhao, H., Liu, Z., Shen, H., Jin, S., Zhang, S., Glycyrrhizic acid pretreatment prevents sepsis-induced acute kidney injury via suppressing inflammation, apoptosis and oxidative stress. Eur. J. Pharmacol., 2016.